Abstract: A wireless access node serves wireless communication devices over a radio channel that is allocated into subchannels for wireless network slices. The wireless access node determines the wireless network slices used by the wireless communication devices. The wireless access node schedules resource blocks in the subchannels for the wireless network slices to the wireless communication devices based on the wireless network slices used by the wireless communication devices. The wireless access node wirelessly exchanges user data with the wireless communication devices over the scheduled resource blocks in the subchannels for the wireless network slices. The wireless access node re-sizes the subchannels for the wireless network slices based on time-of-day.

Abstract: A wireless communication network serves wireless user devices over a radio channel that is allocated into subchannels for wireless network slices. A wireless access node schedules resource blocks from the subchannels to the wireless user devices based on their wireless network slices. The wireless access node detects a subchannel has available resource blocks and other subchannels need the available resource blocks. The wireless access node schedules the available resource blocks to the wireless user devices that need the available resource blocks and that use a higher priority wireless network slice. The wireless access node wirelessly exchanges user data with the wireless user devices over the scheduled resource blocks and exchanges the user data with the wireless network slices. The wireless network slices exchanging at least some of the user data with external systems.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae: wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2e and R2d have the meanings provided in the specification.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae Formula (I), (II), (III), (iv): wherein the letters and symbols a, b, c, d, e, f, g, Z, R1b, R2a and R2b have the meanings provided in the specification.

Abstract: Provided are methods for expanding stem cells and/or lineage committed progenitor cells, such as hematopoietic stems cells and/or lineage committed progenitor cells, at least in part, by using compounds that antagonize AhR. The compounds are represented by formulae: wherein the letters and symbols a, b, c, d, e, f, g, Z, R1b, R2a and R2b have the meanings provided in the specification. Also provided are compositions comprising stem cells and/or lineage committed progenitor cells expanded by methods disclosed herein and methods for the treatment of diseases treatable by same.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae: wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2c and R2d have the meanings provided in the specification.

Abstract: Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Abstract: A wireless communication network serves wireless user devices over a radio channel that is allocated into subchannels for wireless network slices. A wireless access node schedules resource blocks from the subchannels to the wireless user devices based on their wireless network slices. The wireless access node detects a subchannel has available resource blocks and other subchannels need the available resource blocks. The wireless access node schedules the available resource blocks to the wireless user devices that need the available resource blocks and that use a higher priority wireless network slice. The wireless access node wirelessly exchanges user data with the wireless user devices over the scheduled resource blocks and exchanges the user data with the wireless network slices. The wireless network slices exchanging at least some of the user data with external systems.

Abstract: Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Abstract: Provided are methods for expanding stem cells and/or lineage committed progenitor cells, at least in part, by using lactam compounds that antagonize AhR. The compounds are represented by formula (I): wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2c and R2d have the meanings provided below. Also provided are compositions comprising stem cells and/or lineage committed progenitor cells expanded by methods disclosed herein and methods for the treatment of diseases treatable by same.

Abstract: Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Abstract: A wireless access node serves wireless user devices with different services over a common radio channel. The different services are supported by different wireless network slices. The wireless access node determines service subchannels in the radio channel based on location and time. The wireless access node schedules resource blocks from the subchannels for their corresponding services. If a subchannel for one service is full, then the wireless access node schedules the remaining data for the service in the unscheduled resource blocks of the other subchannels if any. The wireless access node wirelessly exchanges data for the services with the wireless user devices over the scheduled resource blocks in the subchannels of the radio channel. The wireless access node exchanges the data with the wireless network slices that support the services.

Abstract: Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Abstract: A wireless access node serves wireless user devices with different services over a common radio channel. The different services are supported by different wireless network slices. The wireless access node determines service subchannels in the radio channel based on location and time. The wireless access node schedules resource blocks from the subchannels for their corresponding services. If a subchannel for one service is full, then the wireless access node schedules the remaining data for the service in the unscheduled resource blocks of the other subchannels if any. The wireless access node wirelessly exchanges data for the services with the wireless user devices over the scheduled resource blocks in the subchannels of the radio channel. The wireless access node exchanges the data with the wireless network slices that support the services.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae Formula (I), (II), (III), (iv): wherein the letters and symbols a, b, c, d, e, f, g, Z, R1b, R2a and R2b have the meanings provided in the specification.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae: wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2c and R2d have the meanings provided in the specification.

Abstract: Provided herein are compounds, compositions and methods of using the compounds and compositions for the treatment of diseases modulated, as least in part, by AhR. The compounds are represented by formulae: wherein the letters and symbols X1, X2, Z, R1b, R1c, R1d, R1e, R2a, R2b, R2c and R2d have the meanings provided in the specification.

Abstract: Wireless communication devices have antennas, and the antennas have earth-orientations. The wireless devices exchange network signaling with a wireless access node over the antennas. Some of network signaling indicates Device-to-Device (D2D) communication times and frequencies. The wireless communication devices exchange device signaling with each other over the antennas using the D2D communication times and frequencies. Some of the device signaling indicates the earth orientations for the antennas. The wireless communication devices select a subset of the antennas based on the earth orientations. The wireless communication devices exchange user data with each other over the selected subset of antennas using the D2D communication times and frequencies.

Abstract: Wireless communication devices have antennas, and the antennas have earth-orientations. The wireless devices exchange network signaling with a wireless access node over the antennas. Some of network signaling indicates Device-to-Device (D2D) communication times and frequencies. The wireless communication devices exchange device signaling with each other over the antennas using the D2D communication times and frequencies. Some of the device signaling indicates the earth orientations for the antennas. The wireless communication devices select a subset of the antennas based on the earth orientations. The wireless communication devices exchange user data with each other over the selected subset of antennas using the D2D communication times and frequencies.

Abstract: A battery-powered wireless communication device has internal antennas. In the wireless communication device, transceiver circuitry wirelessly receives external antenna data that indicates on/off status, reserve battery power, and geometric earth-orientation for the individual antennas in a different wireless communication device. Baseband circuitry determines internal antenna data that indicates the on/off status, reserve battery power, and geometric earth-orientation for the internal antennas. The baseband circuitry executes a user application that generates and consumes user data. The baseband circuitry selects a set of the internal antennas to serve the user application based on the internal antenna data and the external antenna data. The transceiver circuitry wirelessly exchanges the user data over the selected set of the internal antennas.